RecruitingEarly Phase 1NCT06762873

Assessment of OSA in Latin American and Response to Neuromod Therapy

Assessment of Obstructive Sleep Apnea in the Latin American Population and Response to Neuromodulation Therapy to Treat Obstructive Sleep Apnea


Sponsor

Lunair Medical

Enrollment

50 participants

Start Date

Nov 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to characterize the upper airway of Latin American subjects who have been diagnosed with moderate/severe obstructive sleep apnea (OSA) and assess response to a neuromodulation therapy to treat OSA.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Drug Induced Sleep Endoscopy with PNS for people with obstructive sleep apnea. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDrug Induced Sleep Endoscopy with PNS

Enrolled subjects will complete an overnight PSG and then undergo a DISE procedure with a 30-minute research period.


Locations(1)

Sanatorio Americano

Asunción, Paraguay

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06762873


Related Trials